Format
Sort by
Items per page

Send to

Choose Destination

Best matches for oxytocin schizophrenia:

Oxytocin and Schizophrenia Spectrum Disorders. Ettinger U et al. Curr Top Behav Neurosci. (2018)

The effects of adjunctive intranasal oxytocin in patients with schizophrenia. Ota M et al. Postgrad Med. (2018)

Oxytocin effects in schizophrenia: Reconciling mixed findings and moving forward. Bradley ER et al. Neurosci Biobehav Rev. (2017)

Search results

Items: 1 to 20 of 262

1.

Co-shared genetics and possible risk gene pathway partially explain the comorbidity of schizophrenia, major depressive disorder, type 2 diabetes, and metabolic syndrome.

Postolache TT, Del Bosque-Plata L, Jabbour S, Vergare M, Wu R, Gragnoli C.

Am J Med Genet B Neuropsychiatr Genet. 2019 Feb 6. doi: 10.1002/ajmg.b.32712. [Epub ahead of print] Review.

PMID:
30729689
2.

Oxytocin does not improve working memory in schizophrenia.

Bradley ER, van Nieuwenhuizen A, Abram S, Niles AN, Woolley JD.

Schizophr Res. 2019 Jan 31. pii: S0920-9964(19)30017-9. doi: 10.1016/j.schres.2019.01.020. [Epub ahead of print] No abstract available.

PMID:
30712813
3.

Assessing the relationship between attachment, parental attitude and plasma oxytocin in schizophrenia patients and their unaffected siblings.

Aydın O, Balıkçı K, Taş C, Ünal-Aydın P, Taneli F, Esen-Danacı A.

Nord J Psychiatry. 2019 Jan 14:1-7. doi: 10.1080/08039488.2018.1554698. [Epub ahead of print]

PMID:
30636461
4.

A ghrelin receptor and oxytocin receptor heterocomplex impairs oxytocin mediated signalling.

Wallace Fitzsimons SE, Chruścicka B, Druelle C, Stamou P, Nally K, Dinan TG, Cryan JF, Schellekens H.

Neuropharmacology. 2018 Dec 21. pii: S0028-3908(18)30912-2. doi: 10.1016/j.neuropharm.2018.12.022. [Epub ahead of print] Review.

PMID:
30582955
5.

Adjunctive intranasal oxytocin for schizophrenia: A meta-analysis of randomized, double-blind, placebo-controlled trials.

Zheng W, Zhu XM, Zhang QE, Yang XH, Cai DB, Li L, Li XB, Ng CH, Ungvari GS, Ning YP, Xiang YT.

Schizophr Res. 2018 Dec 17. pii: S0920-9964(18)30695-9. doi: 10.1016/j.schres.2018.12.007. [Epub ahead of print] Review.

PMID:
30573406
6.

Peripheral oxytocin and vasopressin modulates regional brain activity differently in men and women with schizophrenia.

Rubin LH, Li S, Yao L, Keedy SK, Reilly JL, Hill SK, Bishop JR, Sue Carter C, Pournajafi-Nazarloo H, Drogos LL, Gershon E, Pearlson GD, Tamminga CA, Clementz BA, Keshavan MS, Lui S, Sweeney JA.

Schizophr Res. 2018 Dec;202:173-179. doi: 10.1016/j.schres.2018.07.003. Epub 2018 Jul 6.

PMID:
30539769
7.

Targeting the Oxytocin System: New Pharmacotherapeutic Approaches.

Gulliver D, Werry E, Reekie TA, Katte TA, Jorgensen W, Kassiou M.

Trends Pharmacol Sci. 2019 Jan;40(1):22-37. doi: 10.1016/j.tips.2018.11.001. Epub 2018 Nov 30. Review.

PMID:
30509888
8.

Endogenous oxytocin response to film scenes of attachment and loss is pronounced in schizophrenia.

Speck LG, Schöner J, Bermpohl F, Heinz A, Gallinat J, Majic T, Montag C.

Soc Cogn Affect Neurosci. 2019 Jan 4;14(1):109-117. doi: 10.1093/scan/nsy110.

9.

Posterior pituitary neurohormonal disturbances in schizophrenia and role of oxytocin in treatment - need for more short- and long-term studies.

Gul O, Gul S, Godil AA.

Neuropsychiatr Dis Treat. 2018 Oct 5;14:2579-2582. doi: 10.2147/NDT.S183645. eCollection 2018. No abstract available.

10.

Oxytocin and excitation/inhibition balance in social recognition.

Lopatina OL, Komleva YK, Gorina YV, Olovyannikova RY, Trufanova LV, Hashimoto T, Takahashi T, Kikuchi M, Minabe Y, Higashida H, Salmina AB.

Neuropeptides. 2018 Dec;72:1-11. doi: 10.1016/j.npep.2018.09.003. Epub 2018 Sep 21. Review.

PMID:
30287150
11.

Oxytocin differentially modulates specific dorsal and ventral striatal functional connections with frontal and cerebellar regions.

Zhao Z, Ma X, Geng Y, Zhao W, Zhou F, Wang J, Markett S, Biswal BB, Ma Y, Kendrick KM, Becker B.

Neuroimage. 2019 Jan 1;184:781-789. doi: 10.1016/j.neuroimage.2018.09.067. Epub 2018 Sep 25.

PMID:
30266264
12.

Pharmacological interventions in social cognition deficits: A systematic mapping review.

Fernández-Sotos P, Navarro E, Torio I, Dompablo M, Fernández-Caballero A, Rodriguez-Jimenez R.

Psychiatry Res. 2018 Dec;270:57-67. doi: 10.1016/j.psychres.2018.09.012. Epub 2018 Sep 11.

PMID:
30245378
13.

Effects of oxytocin on empathy, introspective accuracy, and social symptoms in schizophrenia: A 12-week twice-daily randomized controlled trial.

Halverson T, Jarskog LF, Pedersen C, Penn D.

Schizophr Res. 2018 Sep 19. pii: S0920-9964(18)30571-1. doi: 10.1016/j.schres.2018.09.013. [Epub ahead of print]

PMID:
30243853
14.

Add-on Yoga Therapy for Social Cognition in Schizophrenia: A Pilot Study.

Govindaraj R, Naik S, Manjunath NK, Mehta UM, Gangadhar BN, Varambally S.

Int J Yoga. 2018 Sep-Dec;11(3):242-244. doi: 10.4103/ijoy.IJOY_45_17.

15.

Chronic nicotine administration restores brain region specific upregulation of oxytocin receptor binding levels in a G72 mouse model of schizophrenia.

Zanos P, Keyworth H, Georgiou P, Hambsch B, Otte DM, Kitchen I, Zimmer A, Bailey A.

Eur J Neurosci. 2018 Sep 15. doi: 10.1111/ejn.14155. [Epub ahead of print]

PMID:
30218618
16.

[Oxytocin in schizophrenia : Evidence for an etiological and therapeutic relevance of the social neuromodulator].

Luckhaus C, Juckel G, Hurlemann R.

Nervenarzt. 2018 Sep 13. doi: 10.1007/s00115-018-0615-0. [Epub ahead of print] Review. German.

PMID:
30215130
17.

The effects of combined oxytocin and cognitive behavioral social skills training on social cognition in schizophrenia.

Strauss GP, Granholm E, Holden JL, Ruiz I, Gold JM, Kelly DL, Buchanan RW.

Psychol Med. 2018 Sep 5:1-9. doi: 10.1017/S0033291718002465. [Epub ahead of print]

PMID:
30180918
18.

Oxytocin attenuates phencyclidine hyperactivity and increases social interaction and nucleus accumben dopamine release in rats.

Kohli S, King MV, Williams S, Edwards A, Ballard TM, Steward LJ, Alberati D, Fone KCF.

Neuropsychopharmacology. 2019 Jan;44(2):295-305. doi: 10.1038/s41386-018-0171-0. Epub 2018 Aug 7.

PMID:
30120410
19.

A dose-finding study of oxytocin using neurophysiological measures of social processing.

Wynn JK, Green MF, Hellemann G, Reavis EA, Marder SR.

Neuropsychopharmacology. 2019 Jan;44(2):289-294. doi: 10.1038/s41386-018-0165-y. Epub 2018 Jul 28.

PMID:
30082892
20.

Imaging neuropeptide effects on human brain function.

Lefevre A, Hurlemann R, Grinevich V.

Cell Tissue Res. 2019 Jan;375(1):279-286. doi: 10.1007/s00441-018-2899-6. Epub 2018 Aug 1. Review.

PMID:
30069597

Supplemental Content

Loading ...
Support Center